1. Wu, Z.; Huang, Y.; Yuan, W.; Wu, X.; Shi, H.; Lu, M.; Xu, A., Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer. Front Oncol, 2022. 12: p. 1056917.
2. Shi, H.; Duan, J.; Wang, J.; Li, H.; Wu, Z.; Wang, S.; Wu, X.; Lu, M., 1,25(OH)(2)D(3) Promotes Macrophage Efferocytosis Partly by Upregulating ASAP2 Tranion via the VDR-Bound Enhancer Region and ASAP2 May Affect Antiviral Immunity. Nutrients, 2022. 14(22).
3. Shi, H.; Duan, J.; Chen, Z.; Huang, M.; Han, W.; Kong, R.; Guan, X.; Qi, Z.; Zheng, S.; Lu, M., A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG. Clin Transl Oncol, 2022.
4. Lu, M.; Shi, H.; Taylor, B.V.; Körner, H., Alterations of subset and cytokine profile of peripheral T helper cells in PBMCs from Multiple Sclerosis patients or from individuals with MS risk SNPs near genes CYP27B1 and CYP24A1. Cytokine, 2022. 153: p. 155866.
5. Li, J.; Shi, H.; Yuan, Z.; Wu, Z.; Li, H.; Liu, Y.; Lu, M.; Lu, M., The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration. BMC Cancer, 2022. 22(1): p. 108.
6. Lu, M.; McComish, B.J.; Burdon, K.P.; Taylor, B.V.; Körner, H., The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)(2)D(3) Induces Super-Enhancers Bound by VDR. Front Immunol, 2019. 10: p. 488.
7. Lu, M.; Taylor, B.V.; Körner, H., Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis. Front Immunol, 2018. 9: p. 477.
